Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study

2016 ◽  
Vol 5 (3) ◽  
pp. 180-187
Author(s):  
Ajit Suri ◽  
Sandeepraj Pusalkar ◽  
Yuexian Li ◽  
Shimoga Prakash
Keyword(s):  
Single Dose ◽  
Phase 1 ◽  
Healthy Male ◽  
Open Label ◽  
Single Dose Study ◽  
Investigational Agent ◽  
Dose Study ◽  
Male Subjects

A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment

2020 ◽  
Vol 61 (6) ◽  
pp. 1355-1363
Author(s):  
Ying C. Ou ◽  
Richard A. Preston ◽  
Thomas C. Marbury ◽  
Zhiyu Tang ◽  
William Novotny ◽  
...  
Keyword(s):  
Single Dose ◽  
Hepatic Impairment ◽  
Phase 1 ◽  
Open Label ◽  
Single Dose Study ◽  
Dose Study

scholarly journals A phase-1, open-label, single-dose study of the pharmacokinetics of buparlisib in subjects with mild to severe hepatic impairment

2015 ◽  
Vol 56 (3) ◽  
pp. 316-323 ◽  
Author(s):  
Denes Csonka ◽  
Katharine Hazell ◽  
Edward Waldron ◽  
Sebastien Lorenzo ◽  
Vincent Duval ◽  
...  
Keyword(s):  
Single Dose ◽  
Hepatic Impairment ◽  
Phase 1 ◽  
Severe Hepatic Impairment ◽  
Open Label ◽  
Single Dose Study ◽  
Dose Study

1027-P: A Phase 1, Open-Label, Single-Dose Study to Evaluate Pharmacokinetics of MEDI0382 in Patients with Renal Impairment

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1027-P
Author(s):  
GERNOT K. KLEIN ◽  
MARCELLA PETRONE ◽  
YE YANG ◽  
THUONG HOANG ◽  
SHEILA DICOSTANZA ◽  
...  
Keyword(s):  
Single Dose ◽  
Renal Impairment ◽  
Phase 1 ◽  
Open Label ◽  
Single Dose Study ◽  
Dose Study
Sign in / Sign up

Export Citation Format

Share Document